Metabolic context affects hemodynamic response to bupivacaine in the isolated rat heart

Chemico-Biological Interactions

Volumn 172, Issue 1, 2008, Pages 48-53

  Edelman, Lucas B ^a   Ripper, Richard ^b   Kelly, Kemba ^b   Di Gregorio, Guido ^b   Weinberg, Guy L ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Bupivacaine; Cardiotoxicity; Fatty acid metabolism; Isolated heart; Local anesthesia; Metabolic modulation

Indexed keywords

BUPIVACAINE; CARBOHYDRATE; FATTY ACID; OCTANOIC ACID; OLEIC ACID;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASYSTOLE; CARBOHYDRATE METABOLISM; CARDIOTOXICITY; CONCENTRATION RESPONSE; FATTY ACID METABOLISM; HEART; HEART ARRHYTHMIA; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HEART PERFUSION; HEMODYNAMICS; ISOLATED HEART; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; METABOLISM; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CARBOHYDRATE METABOLISM; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; HEART; HEMODYNAMICS; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 39549104713     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.10.007     Document Type: Article

References (23)

1. Weinberg G. Lipid rescue resuscitation from local anaesthetic cardiac toxicity. Toxicol. Rev. 25 3 (2006) 139-145
2. Clarkson C.W., and Hondeghem L.M. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 62 4 (1985) 396-405
3. Lynch III C. Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine. Anesth. Analg. 65 6 (1986) 551-559
4. Castle N.A. Bupivacaine inhibits the transient outward K+ current but not the inward rectifier in rat ventricular myocytes. J. Pharmacol. Exp. Ther. 255 3 (1990) 1038-1046
5. Butterworth F.T., Brownlow R.C., Leith J.P., Prielipp R.C., and Cole L.R. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. Anesthesiology 79 1 (1993) 88-95
6. Sztark F., Malgat M., Dabadie P., and Mazat J. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial energetics. Anesthesiology 88 5 (1998) 1340-1349
7. Weinberg G.L., Palmer J.W., VadeBoncouer T.R., Zuechner M.B., Edelman G., and Hoppel C.L. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology 92 2 (2000) 523-528
8. R.L. Collins-Nakai, D. Noseworthy, G.D. Lopaschuk, Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism, Am. J. Physiol. 267(5Pt2) (1994) H1862-H1871.
9. Cooper M.W. Postextrasystolic potentiation. Do we really know what it means and how to use it?. Circulation 88 6 (1993) 2962-2971
10. Cho H.S., Lee J.J., Chung I.S., Shin B.S., Kim J.A., and Lee K.H. Insulin reverses bupivacaine-induced cardiac depression in dogs. Anesth. Analg. 91 5 (2000) 1096-1102
11. Kim J.T., Jung C.W., and Lee K.H. The effect of insulin on the resuscitation of bupivacaine-induced severe cardiovascular toxicity in dogs. Anesth. Analg. 99 3 (2004) 728-733 (table of contents)
12. Weinberg G.L., Ripper R., Murphy P., Edelman L.B., Hoffman W., Strichartz G., and Feinstein D.L. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg. Anesth. Pain Med. 31 4 (2006) 296-303
13. Rosenblatt M.A., Abel M., Fischer G.W., Itzkovich C.J., and Eisenkraft J.B. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 105 1 (2006) 217-218
14. Litz R.J., Popp M., Stehr S.N., and Koch T. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia 61 8 (2006) 800-801
15. Foxall G., McCahon R., Lamb J., Hardman J.G., and Bedforth N.M. Levobupivacaine-induced seizures and cardiovascular collapse treated with intralipid. Aneasthesia 62 5 (2007) 516-518
16. Spence A.G. Lipid reversal of central nervous system symptoms of bupivacaine toxicity. Anesthesiology 107 3 (2007) 516-517
17. Hendrickson S.C., St Louis J.D., Lowe J.E., and Abdel-aleem S. Free fatty acid metabolism during myocardial ischemia and reperfusion. Mol. Cell. Biochem. 166 1-2 (1997) 85-94
18. Adams R.J., Cohen D.W., Gupte S., Johnson J.D., Wallick E.T., Wang T., and Schwartz A. In vitro effects of palmitylcarnitine on cardiac plasma membrane Na,K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport. J. Biol. Chem. 254 24 (1979) 12404-12410
19. Wojtczak L., and Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim. Biophys. Acta 1183 1 (1993) 41-57
20. Weinberg G.L., Laurito C.E., Geldner P., Pygon B.H., and Burton B.K. Malignant ventricular dysrhythmias in a patient with isovaleric acidemia receiving general and local anesthesia for suction lipectomy. J. Clin. Anesth. 9 8 (1997) 668-670
21. Ross J.D., Ripper R., Law W.R., Massad M., Murphy P., Edelman L., Conlon B., Feinstein D.L., Palmer J.W., DiGregorio G., and Weinberg G.L. Adding bupivacaine to high-potassium cardioplegia improves function and reduces cellular damage of rat isolated hearts after prolonged, cold storage. Anesthesiology 105 4 (2006) 746-752
22. Weinberg G.L., and Massad M.G. Metabolic modulation for cardiac protection. Expert Rev. Cardiovasc. Ther. 5 2 (2007) 135-138
23. Weinberg G., Paisanthasan C., Feinstein D., and Hoffman W. The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth. Analg. 98 3 (2004) 790-795